Retinoid-induced epiphyseal plate closure in guinea pigs

Fundamental and Applied Toxicology

Volumn 34, Issue 1, 1996, Pages 91-98

  Standeven, Andrew M ^a,b,c   Davies, Peter J A ^a,d   Chandraratna, Roshantha A S ^a,b   Mader, Douglas R ^a,c   Johnson, Alan T ^a,b   Thomazy, Vilmos A ^a,d  

^a Retinoid Research   (United States)

^b Department of Biology ^*  (United States)

^c ALLERGAN INC   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DISEASE; EPIPHYSIS INJURY; EPIPHYSIS PLATE; EXTRACELLULAR MATRIX; GUINEA PIG; HISTOLOGY; MALE; NONHUMAN; PREMATURITY;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 85033062266     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0179     Document Type: Article

References (33)

1. Armstrong, R. B., Ashenfelter, K. O., Eckhoff, C. Levin, A. A., and Shapiro, S. S. (1994). General and reproductive toxicology of retinoids. In The Retinoids: Biology, Chemistry, and Medicine (M. B. Sporn, A. B. Roberts, and D. S. Goodman, Eds.), pp. 545-572. Raven Press, New York.
2. Benya, P. D., and Padilla, S. R. (1986). Modulation of the rabbit chondrocyte phenotype by retinoic acid terminates type II collagen synthesis without inducing type I collagen: The modulated phenotype differs from that produced by subculture. Dev. Biol. 118, 296-305.
3. Boehm, M. F., Heyman, R. A., Patel, S., Stein, R. B., and Nagpal, S. (1995). Retinoids: Biological function and use in the treatment of dermatological diseases. Exp. Opin. Invest. Drugs 4, 593-612.
4. Chandraratna, R. A. S., Gillett, S. J., Song, T. K., Attard, J., Vuligonda, S., Garst, M. E., Arefieg, T., Gil, D. W., and Wheeler, L. (1995a). Synthesis and pharmacological activity of conformationally restricted, acetylenic retinoid analogs. Bioorg. Med. Chem. Lett. 5, 523-527.
5. Chandraratna, R. A. S., Henry, E., Attard, J., Gillett, S. J., Song, T., Garst, M. E., Nagpal, S., Athanikar, J., Arefieg, T., Gil, D. W., Wheeler, L. A., Lew-Kaya, D., and Sefton, J. (1995b). Development of RAR subtype selective retinoids for dermatological diseases. Eur. J. Med. Chem. 30, 505s-517s.
6. Eckhardt, K., and Schmitt, G. (1994). A retinoic acid recptor α antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo. Toxicol. Lett. 70, 299-308.
7. Graf, N., Riesinger, P., and Reinhard, H. (1995). Retinoids in the treatment of acute promyelocytic leukemia. Klin. Padiatr. 207, 43-47.
8. Hembree, J. R., Agarwal, C., Beard, R. L., Chandraratna, R. A. S., and Eckert, R. L. (1996). Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical cells. Cancer Res. 56, 1794-1799.
9. Horton, W. E., Yamada, Y., and Hassell, J. R. (1987). Retinoic acid rapidly reduces cartilage matrix synthesis by altering gene transcription in chondrocytes. Dev. Biol. 123, 508-516.
10. Johnson, A. T., Klein, E. S., Gillett, S. J., Wang, L., Song, T. K., Pino, M., and Chandraratna, R. A. S. (1995). Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem. 38, 4764-4767.
11. Kaplan, G., and Haettich, B. (1991). Rheumatological symptoms due to retinoids. Bailliere's Clin. Rheumatol. 5, 77-97.
12. Keene, A. T., Farndon, F. F., Tucker, M. J., Willars, G. B., Ward, S. J., and Turton, J. A. (1991). All-trans-retinoic acid (TRA) induces premature closure of the long bone epiphyses in the guinea pig. Hum. Exp. Toxicol. 10, 503-504.
13. Kimmel, D. B. (1991). Quantitative histologic changes in the proximal tibial growth cartilage of aged female rats. Cells Materials Suppl. 1, 11-18.
14. Kistler, A. (1981). Structure-activity relationship of retinoids in fetal rat bone cultures. Calcif. Tissue Int. 33, 249-254.
15. Kochar, D. M., and Penner, J. D. (1987). Developmental effects of isotretinoin and 4-oxo-isotretinoin: The role of metabolism in teratogenicity. Teratology 36, 67-75.
16. Loeliger, P., Bollag, W., and Mayer, H. (1980). Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. 15, 9-15.
17. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. (1994). The retinoid receptors. In The Retinoids: Biology, Chemistry, and Medicine (M. B. Sporn, A. B. Roberts, and D. S. Goodman, Eds.), pp. 319-349. Raven Press, New York.
18. Marini, J. C., Hill, S., and Zasloff, M. A. (1988). Dense metaphyseal bands and growth arrest associated with isotretinoin therapy. Am. J. Dis. Child. 142, 316-318.
19. Milstone, L. M., McGuire, J., and Ablow, R. C. (1982). Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J. Am. Acad. Dermatol. 7, 663-666.
20. Morales, T. I., and Roberts, A. B. (1992). The interaction between retinoic acid and the transforming growth factors-β in calf articular cartilage cultures. Arch. Biochem. Biophys. 293, 79-84.
21. Nagpal, S., Athanikar, J., and Chandraratna, R. A. S. (1995). Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J. Biol. Chem. 270, 923-927.
22. Pease, C. N. (1962). Focal retardation and arrestment of growth of bones dues to vitamin A intoxication. J. Am. Med. Assoc. 182, 980-985.
23. Pignatello, M. A., Kauffman, F. C., and Levin, A. A. (1995). Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (RO 13-7410). Toxicologist 15, 159.
24. Prendiville, J., Bingham, E. A., and Burrows, D. (1986). Premature epiphyseal closure - A complication of etretinate therapy in children. J. Am. Acad. Dermatol. 15, 1259-1262.
25. Ruby, L. K., and Mital, M. A. (1974). Skeletal deformities following chronic hypervitaminosis A. J. Bone Joint Surg. 56-A, 1283-1287.
26. Standeven, A. M., Davies, P. A., Thomazy, V., Castilleja, O., and Chandraratna, R. A. (1995). Retinoid-induced epiphyseal closure in male Hartley guinea pigs. Toxicologist 15, 367.
27. Standeven, A. M., Johnson, A. T., Escobar, M., and Chandraratna, R. A. S. (1996). Specific antagonist of retinoid toxicity in mice. Toxicol. Appl. Pharmacol. 138, 169-175.
28. Stevens, A. (1990). The hematoxylin. In Theory and Practice of Histological Techniques (J. D. Bancroft and A. Stevens, Eds.), pp. 107-118. Churchill Livingstone, Edinburgh.
29. Teelmann, K. (1981). Experimental toxicology of the aromatic retinoid Ro 10-9359 (Etretinate). In Retinoids. Advances in Basic Research and Therapy (C. E. Orfanos, O. Braun-Falco, E. M. Farber, C. Grupper, M. K. Polano, and R. Schuppli, Eds.), pp. 41-47. Springer-Verlag, Berlin.
30. Trechsel, U., Stutzer, A., and Fleisch, H. (1987). Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats: New model to study bone resorption in vivo. J. Clin. Invest. 80, 1679-1686.
31. Turton, J. A., Hicks, R. M., Gwynne, J., Hunt., R., and Hawkey, C. M. (1985). Retinoid toxicity. Ciba Found. Symp. 113, 220-251.
32. Wolbach, B. (1947). Vitamin-A deficiency and excess in relation to skeletal growth. J. Bone Joint Surg. 29, 171-192.
33. Zuck, T. T. (1938). Age order of epiphyseal union in the guinea pig. Anat. Rec. 70, 389-399.